Form 4: Clover Health Investments, Corp. /De Director Receives Stock
Insider Transaction (Form 4)
Brian James Miller, a Director of Clover Health Investments, Corp. /De, received 12,481 shares of common stock on September 30, 2026.
Summary
- Grant/award: acquired 12,481 Class A Common Stock on September 30, 2026; holds 12,481 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Brian James Miller — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant/award | Class A Common Stock | 12,481 | — | — | 12,481 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Grant/award (12,481 shares) |
Keywords
insider transaction, Form 4, CLOV, CLOVER HEALTH INVESTMENTS, CORP. /DE, neutral, Brian James Miller
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.